Clincosm LogoSign in Get a demo

Merkel Cell Carcinoma

Showing 26 - 50 of 73
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV, Merkel Cell Carcinoma Trial (IFx-Hu2.0)

Available
  • Cutaneous Melanoma, Stage III
  • +3 more
  • IFx-Hu2.0
  • (no location specified)
Aug 5, 2022

Merkel Cell Carcinoma, Small Cell Lung Cancer Trial in United States (XmAb18087, XmAb18087 ± Pembrolizumab)

Completed
  • Merkel Cell Carcinoma
  • Small Cell Lung Cancer
  • XmAb18087
  • XmAb18087 ± Pembrolizumab
  • Duarte, California
  • +6 more
Aug 8, 2022

Merkel Cell Carcinoma Trial in Worldwide (KRT-232, Avelumab)

Recruiting
  • Merkel Cell Carcinoma
  • Aurora, Colorado
  • +38 more
Aug 3, 2022

Merkel Cell Carcinoma Trial in Seattle (ITI-3000)

Recruiting
  • Merkel Cell Carcinoma
  • Seattle, Washington
    University of Washington/Seattle Cancer Care Alliance
Aug 1, 2022

Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +

Recruiting
  • Gastric Cancer
  • +9 more
  • Tumor Infiltrating Lymphocytes (TIL)
  • Fludarabine + Cyclophosphamide combination
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 21, 2022

Melanoma, NSCLC, Squamous Cell Carcinoma of Head and Neck Trial in United States (GEN-011, IL-2, Fludarabine)

Terminated
  • Melanoma
  • +8 more
  • GEN-011
  • +3 more
  • Gilbert, Arizona
  • +7 more
Jul 13, 2022

Solid Tumor, Adult, Metastatic Cancer, Soft Tissue Sarcoma Trial in Belgium, France (BT-001, Pembrolizumab [Keytruda])

Recruiting
  • Solid Tumor, Adult
  • +6 more
  • BT-001
  • Pembrolizumab [Keytruda]
  • Brussels, Belgium
  • +4 more
Jul 13, 2022

Merkel Cell Carcinoma, Skin Cancer Trial in Boston (Cabozantinib)

Active, not recruiting
  • Merkel Cell Carcinoma
  • Skin Cancer
  • Boston, Massachusetts
  • +1 more
Jul 13, 2022

Melanoma, Merkel Cell Carcinoma, Other Solid Tumors Trial in Middletown, Harrison, New York (TALIMOGENE LAHERPAREPVEC (TVEC),

Active, not recruiting
  • Melanoma
  • +2 more
  • TALIMOGENE LAHERPAREPVEC (TVEC)
  • Hypofractionated Radiotherapy
  • Middletown, New Jersey
  • +2 more
Jul 13, 2022

Breast Cancer, Melanoma, Non Small Cell Lung Cancer Trial in Brussel (Checkpoint Blockade, Immune)

Recruiting
  • Breast Cancer
  • +12 more
  • Checkpoint Blockade, Immune
  • Brussel, Anderlecht, Belgium
    Institut Jules Bordet
Jul 1, 2022

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Tampa, Durham (MEM-288 Intratumoral Injection)

Recruiting
  • Solid Tumor
  • +9 more
  • MEM-288 Intratumoral Injection
  • Tampa, Florida
  • +1 more
Jun 27, 2022

Melanoma, Merkel Cell Carcinoma, Triple Negative Breast Cancer Trial in United States (NKTR-262, bempegaldesleukin, nivolumab)

Terminated
  • Melanoma
  • +6 more
  • Scottsdale, Arizona
  • +13 more
Jun 24, 2022

Lung Cancer Metastatic, Renal Cell Carcinoma, Head Neck Cancer Trial in France (Reduced dose intensity of IO)

Recruiting
  • Lung Cancer Metastatic
  • +7 more
  • Reduced dose intensity of IO
  • Angers, France
  • +25 more
Jun 24, 2022

BCC - Basal Cell Carcinoma, SCC - Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Marseille (L19IL2/L19TNF)

Not yet recruiting
  • BCC - Basal Cell Carcinoma
  • +6 more
  • Marseille, France
    Hôpital de la Timone
Jun 22, 2022

Thyroid, Renal Cell Carcinoma, Non Small Cell Lung Cancer Trial in Worldwide (SO-C101, pembrolizumab)

Recruiting
  • Thyroid
  • +18 more
  • New Haven, Connecticut
  • +6 more
Apr 8, 2022

Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Non-Melanoma Skin Cancers Trial in United States (IFx-Hu2.0)

Recruiting
  • Merkel Cell Carcinoma
  • +2 more
  • IFx-Hu2.0
  • Los Angeles, California
  • +3 more
Apr 4, 2022

NSCLC, Small Cell Lung Cancer, Urothelial Carcinoma Trial in United States (N-803 + Pembrolizumab, N-803 + Nivolumab, N-803 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • N-803 + Pembrolizumab
  • +9 more
  • Anchorage, Alaska
  • +34 more
Apr 4, 2022

Non-melanoma Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma Trial in Zurich (Talimogene Laherparepvec (T-VEC))

Completed
  • Non-melanoma Skin Cancer
  • +4 more
  • Talimogene Laherparepvec (T-VEC)
  • Zurich, Switzerland
    Department of Dermatology, University Hospital Zurich
Mar 17, 2022

Merkel Cell Carcinoma Trial in Worldwide (domatinostat in combination with avelumab)

Active, not recruiting
  • Merkel Cell Carcinoma
  • domatinostat in combination with avelumab
  • Leuven, Belgium
  • +21 more
Mar 16, 2022

Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Metastatic Cancer Trial in United States (CMP-001, cemiplimab-rwlc)

Recruiting
  • Merkel Cell Carcinoma
  • +4 more
  • Jacksonville, Florida
  • +6 more
Feb 24, 2022

Lung Tumors, NSCLC, Carcinoma, Small Cell Trial in Worldwide (CK-301 (cosibelimab))

Recruiting
  • Lung Neoplasms
  • +12 more
  • CK-301 (cosibelimab)
  • Wollongong, New South Wales, Australia
  • +47 more
Mar 3, 2022

Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • +10 more
  • Atlanta, Georgia
  • +6 more
Mar 1, 2022

Merkel Cell Carcinoma Trial in United Kingdom (Radiotherapy, Surgery)

Active, not recruiting
  • Merkel Cell Carcinoma
  • Radiotherapy
  • Surgery
  • Birmingham, United Kingdom
  • +13 more
Feb 14, 2022

Merkel Cell Carcinoma Trial in Houston (Radiation therapy)

Recruiting
  • Merkel Cell Carcinoma
  • Radiation therapy
  • Houston, Texas
    M D Anderson Cancer Center
Feb 3, 2022

Merkel Cell Carcinoma Trial in United States (Avelumab, Comprehensive Ablative Radiation Therapy)

Recruiting
  • Merkel Cell Carcinoma
  • Avelumab
  • Comprehensive Ablative Radiation Therapy
  • Basking Ridge, New Jersey
  • +6 more
Jan 5, 2022